TUESDAY, April 14, 2026 -- A novel low-cost assay that sequences cell-free DNA (cfDNA) methylome in blood demonstrates strong performance across a...
Vous n'êtes pas connecté
Maroc - MEDINDIA.NET - Medindia Health News - 20/12/2024 12:34
Explore how circulating cell-free plasma telomere length (cf-TL) serves as a promising biomarker for heart failure.
TUESDAY, April 14, 2026 -- A novel low-cost assay that sequences cell-free DNA (cfDNA) methylome in blood demonstrates strong performance across a...
WEDNESDAY, April 15, 2026 — For the 6 million Americans recovering from heart failure, the most difficult time for their health often starts the...
WEDNESDAY, April 15, 2026 — For the 6 million Americans recovering from heart failure, the most difficult time for their health often starts the...
MethylScan is a new low-cost cell-free DNA methylome test that removes much of the healthy blood DNA background, helping rare disease signals stand...
Osteoarthritis can be treated by a new promising technology of cell-free therapy that uses menstrual blood-derived particles to stimulate cartilage...
Mesoblast has outlined plans to double initial revenues and develop stem cell drugs for lower back pain, heart failure and ...
Mesoblast has outlined plans to double initial revenues and develop stem cell drugs for lower back pain, heart failure and ...
As the science of detecting...
As the science of detecting...
Heart disease is one of the leading causes of death around the world. Among the many types of heart problems, two conditions are very common: heart...